Soleno Therapeutics (SLNO) Non Operating Income (2013 - 2026)
Soleno Therapeutics (SLNO) reported Non Operating Income of $3.6 million for Q1 2026, up 84.52% year-over-year from $2.0 million in Q1 2025, and down 3.86% on a QoQ basis from $3.8 million in Q4 2025.
Soleno Therapeutics (SLNO) has 14 years of Non Operating Income data on file, last reported at $3.6 million in Q1 2026.
- Quarterly Non Operating Income rose 84.52% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.1 million (up 12.18% YoY) and the FY2025 annual result came in at $11.5 million, down 2.92% from the prior year.
- Non Operating Income slipped to $3.6 million in Q1 2026 per SLNO's latest filing, from $3.8 million in the prior quarter.
- Across five years, Non Operating Income topped out at $3.9 million in Q3 2025 and bottomed at -$479000.0 in Q3 2023.
- The 5-year median for Non Operating Income is $2.0 million (2025), against an average of $1.7 million.
- The widest annual swing landed in 2022, when Non Operating Income soared 2100.0%; it then slumped 574.26% in 2023.
- Tracing SLNO's Non Operating Income over 5 years: stood at $155000.0 in 2022, then jumped by 1586.45% to $2.6 million in 2023, then grew by 19.89% to $3.1 million in 2024, then climbed by 20.64% to $3.8 million in 2025, then decreased by 3.86% to $3.6 million in 2026.
- Per Business Quant, the three latest SLNO Non Operating Income figures stand at $3.6 million (Q1 2026), $3.8 million (Q4 2025), and $3.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 3.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.64 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | 3.91 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.97 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | 3.01 Mn |
| Mar 31, 2024 | 2.08 Mn |
| Dec 31, 2023 | 2.61 Mn |
| Sep 30, 2023 | -479,000.00 |
| Jun 30, 2023 | 148,000.00 |
| Mar 31, 2023 | 113,000.00 |
| Dec 31, 2022 | 155,000.00 |
| Sep 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 52,000.00 |
| Mar 31, 2022 | 22,000.00 |
| Dec 31, 2021 | 542,000.00 |
| Sep 30, 2021 | 34,000.00 |
| Jun 30, 2021 | 41,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 11.64 Mn |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 3.81 Mn |
| Mar 31, 2020 | 11,000.00 |
| Dec 31, 2019 | -7.42 Mn |
| Sep 30, 2019 | 29,000.00 |
| Jun 30, 2019 | 47,000.00 |
| Mar 31, 2019 | 57,000.00 |
| Dec 31, 2018 | 2.39 Mn |
| Sep 30, 2018 | 26,000.00 |
| Jun 30, 2018 | -3.22 Mn |
| Mar 31, 2018 | 19,000.00 |
| Dec 31, 2017 | 598,000.00 |
| Sep 30, 2017 | 3,000.00 |
| Jun 30, 2017 | -88,000.00 |
| Mar 31, 2017 | -672,000.00 |
| Dec 31, 2016 | 411,497.00 |
| Sep 30, 2016 | 191,000.00 |
| Jun 30, 2016 | -72,000.00 |
| Mar 31, 2016 | 1.07 Mn |
| Dec 31, 2015 | 662,200.00 |
| Sep 30, 2015 | -110,000.00 |
| Jun 30, 2015 | 4.93 Mn |
| Mar 31, 2015 | -9.23 Mn |
| Dec 31, 2014 | -1.24 Mn |
| Sep 30, 2014 | -1.07 Mn |
| Jun 30, 2014 | -1.49 Mn |
| Mar 31, 2014 | -8,000.00 |
| Dec 31, 2013 | -104,965.00 |
| Sep 30, 2013 | -26,000.00 |